Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma

2017

Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

34

References

13

Citations